(RTTNews) - Verona Pharma plc (VRNA), Friday announced some strategic changes in its capital structure, increasing the company's financial flexibility ... term loan facility to $450 million ...

On Earth, crystallisation of antibody molecules can be challenging due to their large size and flexibility and the ... a pharmaceutical manufacturing facility in space within the next decade ...

RIPSA interests repurchasedTerm loan facility increased to $450 million with more favorable termsAccess to up to an additional $200 millionLONDON ...

Singota Solutions has opened a new facility in Balerna, Switzerland, offering a location touching extensive European ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc ... and amend our term loan facility with Oaktree and OMERS, increasing our financial flexibility and simplifying ...